Andrew Cumella

Jan 1, 2024 | openres.ersjournals.com | Bill King |Andrew Cumella |Nicholas S Hopkinson |John R. Hurst

IntroductionChronic lung diseases are a leading cause of morbidity and mortality worldwide [1]. A key contributor to the burden of chronic lung disease at a patient and health system level is acute exacerbations of respiratory symptoms. These exacerbations are commonly caused by respiratory viral infections [2]. Severe exacerbations that result in hospitalisation are costly and often make up a large majority of the treatment costs of chronic lung disease [3–6].